Dealing with uncertainty in the treatment of

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. The Efficacy of Two Triple Therapy Regimens and One Quadruple Regimen [Omeprazole, Amoxicillin, Metronidazole with Bismuth] in EradicatingReviews on recent clinical trials · 2025
   Trial
2. Clinical Factors Implicated in Antibiotic Resistance inMicroorganisms · 2022
   Review
3. Empirical vs. Susceptibility-Guided Treatment ofFrontiers in microbiology · 2022
   Article
4. Antibiotics as a Stressing Factor Triggering the Harboring ofPathogens (Basel, Switzerland) · 2021
   Article
5. High Effectiveness of a 14-Day Concomitant Therapy forJournal of clinical medicine · 2020
   Article
6. Empirical or susceptibility-guided treatment forTherapeutic advances in gastroenterology · 2020
   Review
7. Telephone-Based Reeducation of Drug Administration forGastroenterology research and practice · 2020
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as